# Eli Lilly Moat

Status: published. Policy: company-analysis-1.

Lilly has a current, finite moat from patents and regulatory data protection supporting most revenues, cash flows and earnings. Strong volume growth and cash generation demonstrate commercial execution, but realized price declines and payer concessions show constrained pricing power. Patent losses, government price setting and continued dependence on successful innovation prevent a wide-moat assessment.

## intangible_assets

Patent and regulatory data protection create commercially meaningful exclusivity. Lilly discloses dependence on protected products for most revenues, cash flows and earnings, with historical rapid revenue declines after protection was lost. Current volume growth supports commercialization success, without proving superiority over particular competitors.

Durability: Finite and product-specific. Trulicity is approaching significant protection losses, while the supplied passages omit the principal products' detailed expiry schedules. Pipeline investment offers potential renewal rather than demonstrated perpetual durability.

Risks: Patent challenges, ineffective enforcement in some markets, competing therapies, compounded incretins and government price setting can erode exclusivity or its economic value. Lower realized prices already demonstrate erosion of pricing power despite strong demand.

Invalidation: The thesis would fail if material protected products suffered sustained volume and cash-generation declines while exclusivity remained intact, or if protection losses and government price reductions caused portfolio erosion that successfully commercialized replacement products could not offset.

Competitors: Not established
- [https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/lly-20251231.htm](https://www.sec.gov/Archives/edgar/data/59478/000005947826000013/lly-20251231.htm) · 2026-02-12
- [https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm](https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm) · 2026-08-05
- [https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm](https://www.sec.gov/Archives/edgar/data/59478/000005947826000029/lly-20260317.htm) · 2026-03-20
- [https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm](https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm) · 2025-02-19
- [https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm](https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm) · 2024-02-21
- [https://www.sec.gov/Archives/edgar/data/59478/000005947826000045/lly-20260331.htm](https://www.sec.gov/Archives/edgar/data/59478/000005947826000045/lly-20260331.htm) · 2026-04-30

[JSON](https://beanvest.com/stock/lly/moat.json)